Sanofi looks for better results than Roche once had for making Tamiflu influenza treatment available OTC in the US as the French pharma licenses exclusive rights from its Swiss counterpart for preparing a switch application and marketing the oseltamivir product if approved.
In Sanofi's July 23 announcement, its consumer health chief, Alan Main, pointed out the US is the largest OTC drug...







